Beth Israel Deaconess Medical Center is a teaching affiliate of Harvard Medical School and is a member of the seven-member Harvard Medical School Consortium, an NCI-designated comprehensive cancer center in the Boston area.
The hospital was founded in 1996 after Beth Israel and Deaconess Hospitals merged to provide enhanced collaboration opportunities. Due to its excellence and dedication to cancer care and treatment, Beth Israel Deaconess Medical Center established a dedicated Cancer Center that provides access to the latest research developments.
Collaboration and affiliation with Harvard Medical School has made Beth Israel Deaconess Cancer Center a top-ranked program nationally and has resulted in continuous funding from the National Institutes of Health.
As a leader in its field, Beth Israel Deaconess Medical Center was recognized in 2012 as a nationally ranked cancer care center by the U.S. News and World Report, its affiliated healthcare system ranked in the top 5 in the US, and has been the recipient of numerous awards for delivering quality, affordable, efficient, effective, and cutting-edge healthcare.
The Beth Israel Deaconess Cancer Center is situated to administer the latest research developments to provide improved cancer treatment options. Beth Israel Deaconess Cancer Center created the Thoracic Oncology Program to create an integrated research environment that provides the collaboration of laboratory scientists and physicians within clinical, translational, and prevention research studies surrounding lung cancer and mesothelioma.
With regard to mesothelioma, the collaboration organizes teams of highly skilled staff to facilitate treatment. The Thoracic Oncology Program works to treat mesothelioma with the International Mesothelioma Program and the Dana-Farber/Brigham and Women’s Hospital, which is consistently ranked as one of the best programs in the country.
After referral or diagnosis by a primary care physician, a team of pathologists, radiologists, surgical and medical oncologists, thoracic surgeons, nurses, pharmacists, dietitians, respiratory therapists, and social workers will handle your case together. Beth Israel Deaconess Cancer Center has extensive expertise in the multi-modal treatment of mesothelioma. Several specific, innovative treatments are being researched, in addition to the comprehensive cancer treatments listed below..
Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state-of-the-art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, support groups, and comprehensive and preventive care are all options in the Beth Israel Deaconess Cancer Center’s cancer treatment program.
Visit Mesothelioma Doctors & Hospitals Near You.